Colossal Biosciences claims to have created genetically engineered "dire wolves" by modifying gray wolf DNA using ancient genetic material from dire wolf remains. However, these animals are not true dire wolves—they are modified gray wolves with only 15 of 80 possible gene changes, and scientists caution that such edits may cause unforeseen health issues like deafness or blindness. The company, valued at over $10 billion, prioritizes biotech innovation and profit over ecological restoration or species conservation. Critics highlight major ethical, scientific, and practical concerns: the process involves harming live animals for egg and embryo collection, lacks regulatory oversight, and may divert attention from protecting endangered species. The animals are currently housed in confined enclosures and not intended for release into the wild. While potential medical and scientific advancements are noted, the broader ecological and ethical implications—especially regarding animal welfare, climate change, and biodiversity—are deeply questionable. The project has generated significant media attention, including a Time magazine cover, but many experts argue it reflects more technological spectacle than genuine ecological benefit. Ultimately, the effort raises urgent questions about the ethics of de-extinction, the motivations behind such projects, and whether they align with sustainable environmental stewardship.
Hi, I'm Wendy Zuckerman, and you're listening to Science Versus.
Earlier this year, there was this huge news
that scientists had brought back the direwolf.
Meet Remus.
And Romulus.
The first two direwolves since the Pleistocene era.
This is a promotional video from the company that made these wolves, Colossal.
And in the video, you can see these gorgeous little white pups.
At just 15 days old, the pups take their first wobbly steps
before a much-needed nap time.
The pups, who are now more than six months old,
were made by taking the DNA of a grey wolf
and then tweaking 14 genes in it to make them bigger,
give them lighter coats, have larger teeth and jaws
than a grey wolf.
And when folks found out about these animals,
there was this huge media buzz,
with headlines plastered all over the place.
One of the wolves even made the cover of Time magazine
with the line, quote,
But is that right?
Did scientists really bring back the direwolf?
What exactly is going on here?
And is this a good idea?
Or could it have dire consequences?
That's what our friends over at Today Explained wanted to know.
So today, we're going to share their episode looking into this.
After the break, co-host of Today Explained,
Sean Ramaswaran, will take it from here.
This episode is brought to you by Chase Sapphire Reserve.
On this podcast, we sort fact from fiction.
So here's a quick truth for you.
With Sapphire Reserve, you can spend all around the world.
Not only that, but you can earn four times the points
on flights and hotels, book direct,
and three times the points on dining.
Plus, enjoy access to award-winning airport lounges
and exclusive restaurant tables.
Learn more at chase.com.
Sapphire Reserve, cards issued by JPMorgan Chase Bank,
and a member FDIC subject to credit approval.
Terms apply.
Are you looking for support in your weight management journey?
ZepBound Terzepatide may be able to help.
ZepBound is a prescription medicine
used with a reduced calorie diet
and increased physical activity
to help adults with obesity
or some adults with overweight
who also have weight-related medical problems
to lose excess body weight
and keep them fit.
To weight off, ZepBound is approved
as a 2.5, 5, 7.5, 10, 12.5, or 15-milligram injection.
ZepBound contains Terzepatide
and should not be used with other Terzepatide-containing products
or any GLP-1 receptor agonist medicines.
It is not known if ZepBound is safe and effective
for use in children.
Don't share needles or pens or reuse needles.
Don't take if allergic to it,
or if you or someone in your family
had medullary thyroid cancer,
or if you've had multiple endocrine neoplasia syndrome,
tell your doctor if you get a lump
or swelling in your neck.
Stop ZepBound and call your doctor
if you have severe stomach pain
or a serious allergic reaction.
Severe side effects may include
inflamed pancreas or gallbladder problems.
Tell your doctor if you experience vision changes
before scheduled procedures with anesthesia,
if you're nursing, pregnant, planned-to-be,
or taking birth control pills.
Taking ZepBound with a sulfonylurea or insulin
may cause low blood sugar.
Side effects include nausea, diarrhea, and vomiting,
which can cause dehydration
and kidney problems.
Talk to your doctor.
Call 1-800-545-5979
or visit zepbound.lily.com.
Dire Wolves.
Not just a thing from Game of Thrones.
Not just Jon Snow's best friend.
Dire Wolves walked the Americas for millennia
up until about 14,000 years ago,
when maybe their primary food source dried up
or humans hunted them to extinction.
No one was taking notes.
But we know they were a bit bigger than gray wolves,
they ate a lot of meat,
and their bite could crush bones.
And now we know that apparently dire wolves are back?
A startup called Colossal says
they've brought these pups back from extinction.
They say they've got three of them,
but are these dire wolves they brought
back from extinction?
Are they actually dire wolves?
And whether they are or aren't,
should we be trying to bring dire wolves back?
Like, why?
Not a lot of people have seen these dire wolves
that have come back from extinction
up close and personal.
Like D.T. Maxx from The New Yorker
is one of the few who has.
Okay, so first of all,
we just got to get this out there.
We either have to put dire wolves in quotes
or we have to give them a name,
like, I don't know, we could do anything like, uh. How about, how about diet dire wolves?
Yes, exactly.
These so-called dire wolves were created
by extracting DNA from a 72,000-year-old
dire wolf inner ear bone
and a 13,000-year-old dire wolf tooth.
They determined its closest living relative
is the gray wolf,
so then they made 20 edits to gray wolf DNA
to include those dire wolf-specific genes.
That animal looks like a dire wolf,
it will behave like a dire wolf,
and it. It is a dire wolf.
This is insane, actually.
These are not dire wolves by any definition.
But the other point is
it doesn't really matter when you're seeing them
because, you know, you're seeing something,
you know, that's absolutely amazing.
I mean, you're seeing something that. So there's two bright white wolves.
I did not see them where they live.
I saw them where they were brought to be seen,
which was far, far away.
And you can't tell us where that was,
but it's somewhere, somewhere in the north
of the northern United States, I've read.
Yeah, look, I do hold bigger secrets as a journalist,
but I'm not supposed to tell you where.
But so what happens. Okay, so first of all,
I see a couple of people I know
from the reporting on the piece.
I see George Church,
who looks as much like Gandalf
as any human being on this planet
who holds tenure.
And I also see Ben Lamb,
the guy who founded the project,
looks a lot like. It's Johnny Snow, right?
The point is, like, it's a perfect setup.
And then there are these two
bright white teenage wolves.
So, you know, even any wolf is impressive.
So it's not. I mean, I have actually seen wolves before
for another article, strangely enough.
So a wolf carries its own weird
kind of authority with it.
But these, they do look different.
And again, I'm not an animal morphologist.
So, you know, I've been told pale,
but they're white.
And they're like celebrities.
I mean, there's no other way, you know,
there's no other way to describe it
that they're delightful,
delightfully, blissfully heedless
of how much, like, money and effort
has gone into the creation of them.
They're basically, you know,
they're in this enclosure.
They're doing little things wolves do
and dogs sometimes do.
One pees, the other rolls in it.
But, you know, they're majestic.
They are going about
their quasi-meta dire wolf existence.
Blissful disregard for any controversy
about what you want to call them.
Blissful disregard of whether
they should have been brought back
in the first place.
Tell us more about this company
that brought back the diet dire wolf
version that you saw.
We could do this all day.
It's called Colossal.
It's run by a dude named Ben Lamb.
Who is he?
What is he trying to do here?
So, I mean, Ben Lamb is kind of amazing.
I am pretty much in awe of Ben Lamb.
Here's a guy who's maybe 40-something,
he's already had like four or five successes
by which he started up four or five companies
and they were bought out by larger companies,
which is kind of what you want to do
when you're a startup guy.
And then, you know, one day he meets a guy
named George Church.
Church being the Gandalf of our earlier narrative,
if that survives.
And Church is a Harvard professor,
a guy who's gotten a million patents
and loves to do deep thinking.
He's a big kind of what-if.
What-if guy.
Like, what if we were to bring back the Neanderthals?
And then the press goes, ah!
And then George Church goes, I was just considering it.
I was just thinking about it.
You guys calm down.
So, George Church and Ben get together
and they, basically what Ben says is,
if you had all the money in the world, George,
what would you bring back?
What would you want to do with your time?
And George says, I'd bring back the woolly mammoth.
Sick.
I mean, I don't know if it's responsible,
but it sounds cool.
Right, right.
Exactly.
And, you know, they get together.
It's like, let's put on a show, right?
And, you know, this being Ben Lamb,
super talented, perfectly adapted,
modern entrepreneur,
and he raises money.
Basically, I don't know the details.
I think he raises money with a phone call
because he's got a great second idea.
And his second idea is,
while we learn how to de-extinct these animals,
we're going to learn an awful lot
of interesting biomedical tech
and that we could sell.
That's where we make our money.
We're not going to make our money.
He's very, very firm on this.
There will be no Jurassic Park.
We will not display these animals.
You know, let's check back in in five years.
But we will spin off the biotech.
And the biotech is honestly probably worth even more than, what is Disney World charged now or Disneyland?
Hundreds, hundreds.
All right, so maybe I take that back.
Maybe the better business is displaying them.
How much money have they raised to do this, and how much is this company that they're running, Colossal, worth at this point?
All right, so they've now raised over $400 million, and their valuation, which is a kind of complicated metric involving what shares are worth, is over $10 billion, which puts it at the size level of Moderna.
They've had an insane, insane first, you know, first few years.
And I ask you this not because, like, Paris Hilton or Peter Jackson.
I'm planning on investing in this company, but because I wanted to establish that people are taking these people seriously.
And now that we've established that, do us a favor and tell us just how hard it is to do what this company says it wants to do.
The dire wolf, you know, is not, let me just get this out there for everybody.
The dire wolf is not, there's a difference between being extinct for 40 million years and being extinct for,
you know, 14,000 years.
They both sound like a long time to us, but, you know, it's just not comparable.
So you can get, you can get, I can't get, you can't get, but Beth Shapiro could get viable ancient DNA.
Now, what you do with that DNA is you read the genetic sequences, and then you recreate them, right?
And you're going to put that DNA into cells, and the cells are going to replicate, and you're going to have an animal, ultimately, once you put it in an embryo and then implant it in a womb,
you're going to have an animal that has those genes being acted on.
That's makes it sound like you or I could probably do it with just a little bit of help, but it's not that easy because there are problems, you know, at every step of the way.
And it's a little bit like, if I described to you how to hit a home run, you'd be like, yeah, okay.
I, you know, there's the force and there's the counter force and there's the angle of the swing, but most people don't hit home runs.
You mentioned someone named Beth Shapiro, who's now, I think, one of the leading scientists over at Colossal.
And someone like Beth Shapiro comes from, I believe, UC Santa Cruz out in California, where she was doing versions of this kind of work, if not trying to, you know, revive the woolly mammoth.
Can Colossal work faster than your, I don't know, typical elite?
Yeah, I mean, I don't think you can get that much money going at a university lab without a fair amount of grant writing.
I mean, grant writing is slow and getting funded is slow.
There's a guy named Lova Dahlen, who's a Swedish woolly mammoth guy.
And I think he made a really good point in my piece that nobody's really picked up on.
And I think it's about the money, which he said, like, the people who invested in this company weren't going to give, you know, I'm paraphrasing him, $100 million.
It's the World Wildlife Fund.
Like, you know, they're tech people.
They probably would have bought Bitcoin with it otherwise.
Like this, you know, Peter Jackson said that owning, being a part of Colossal was as much fun as movie making.
I, I could do that.
You know, I think that kind of tells you something.
I don't think if they'd been doing this in Beth Shapiro's old lab at the University of California, Santa Cruz, he'd have thought it was as much fun, you know, as movie making.
To bring this back to where we started, DT, with Romulus and Remus, these two diet, dire wolves.
What happens to them?
Do you love that?
I do.
I'm going to stick with it.
Where do they go?
You know, never say never, but I think they're expected to live out their lives.
I think a wolf gets the same 15 years, I think, that a smaller dog gets.
Live out their lives.
You know, they will not be.
They will not hunt.
They will be given, like, I don't know if you've ever been to a zoo and seen what they feed the lions and tigers.
They feed them, like, something they would have hunted, but they didn't hunt it.
Like, just oozing, bleeding, massive amounts of meat.
And I think that's what the dire wolves are going to get.
But they're not planning to breed them, which I don't entirely understand.
Colossal talks a lot about, like, reintroducing some of their animals into the ecosystem to do environmental good.
I don't think the dire wolf was conceived by them with that as a possibility.
First of all, I mean, people don't want dire wolves in their backyard.
When you realized that these dire wolves would just die out, did that bum you out?
What did you make of that?
Yes.
Yes, I did.
It was absolutely, you know, there were a number of sad moments in reporting this piece.
I mean, first of all, you have to kind of come to grips with the immensity of the damage that humans,
humans have done and how, for how long we've been doing it.
Because the dire wolf is essentially driven extinct mostly by human activity, you know, 14,000 years ago.
But I don't know.
When you realize that this whole thing is kind of to show we can, yeah, it becomes sad.
Because wasn't, isn't one of the reasons that we used to drive animals extinct because we could?
Because there was money in it?
And isn't it kind of weird?
That we're now de-extincting an animal, you know, kind of because we now have this, this technology that can reopen the door that we see.
We thought that we had absolutely and, and, you know, incontrovertibly closed before.
So the whole thing leaves you a little bit blue.
D.T. Maxx, read his profile of the dire wolves over at newyorker.com.
The ethics of de-extinction.
When Today Explained is back.
You're listening to Today Explained.
I'm Robert Klitzman.
I'm a professor of psychiatry and director of the online and in-person Masters of Bioethics programs at Columbia University.
And the author of Designing Babies, How Technology is Changing the Ways We Create Children.
And when we look at these diet dire wolves in the northern United States somewhere by way of colossal, do we feel more good or bad?
I think there is a lot of excitement.
It's definitely cool.
To bring back extinct species.
But there's a lot of questions we have about where these animals will live, what their lives will be like, why we're doing this, what the long-term view or vision is.
And a lot of that depends on how the technology is then used and what happens.
Well, let's talk about, to start with, what do you think of the ethics of the process by which these dire wolves have come to be?
Obviously, let's just think about whatever animal it was.
Let's talk about what it was that birthed these dire wolves, not a dire wolf, I assume.
Right.
So there's a few issues that come up.
One is we're making a bunch of dogs pregnant to produce them.
And I have concerns about the dire wolves.
But more importantly, the company has said that its longer-term plan is to produce or reproduce or to create a woolly mammoth.
And with that, there are even bigger concerns because that you'd have to take elephants.
You'd have to get many elephants, female elephants, and anesthetize them.
You'd have to stick probes up their vagina to extract eggs.
You'd have to then get many elephants pregnant.
Hopefully, some will not miscarry.
Some will miscarry.
Then you'll have to do C-sections on the elephants to get the woolly mammoths out.
So that's going to be very cumbersome, and it's going to hurt a lot of elephants.
Mm.
So dire wolves, we have three of them that were created.
And I should say they're not really dire wolves.
They're gray wolves that have had about 15 of their genes changed.
So of 80 potential genes that could be changed, they've changed 15.
And when we're mucking around with nature and changing genes, mistakes get made.
Genes have multiple functions that we don't always know about.
So, for instance, five of the genes that Colossal was going to change because they were in dire wolves,
but not in gray wolves, the researchers decided not to change because these genes would create deafness and blindness in the dire wolf.
So we don't always know when we're altering genes what the effects are going to be.
Genes have multiple effects.
About five years ago, Dr. Heijian Kui in China genetically engineered three children.
He took the embryos, and he wanted to disable a gene called the C-section.
HIV positive fathers. But in disabling that gene, other viruses are more likely to enter the cell.
So West Nile virus is more likely to enter the cell. So you may disable the gene because you
want one thing or put a mutation in or change a gene because you want one thing, but other things
may happen. So these wolves may end up having other kinds of medical problems. These are big
animals. They're 150 pounds. Colossal has them on about three square miles, whereas normally they
usually live in areas between 50 and a thousand square miles. So we're keeping them at a very
constricted space. They're at risk of other diseases. So I'm concerned about their welfare.
So it sounds like you have a host of concerns. And throughout listening to you describe many of them,
I hear the potential for death lurking at every corner, which is, I guess, an irony of this
process known as de-extinction, is that it sounds like you sure got to kill a lot of animals.
To get to the point of bringing back an animal that, as we heard from DT earlier,
might end up simply just dying off again. Which I guess gets to the point of cruelty.
Where is the regulation when it comes to this process of de-extinction?
Well, there are no regulations. And that could create problems. So there have been guidelines
that would say, well, we're going to kill a lot of animals. And we're going to kill a lot of animals.
That were developed before we actually had any extinct animals to look at. There was one animal,
a goat in the Pyrenees, the mountains between Spain and France, that was brought back and
lived for 10 minutes. So the guidelines we have aren't very good. And we don't really have any
government. We have no government regulations on this. And in fact, President Trump's Secretary
of the Interior, Doug Borgum, came out the other day and said, it's great that Colossus is doing
this, because now we're going to kill a lot of animals. And we don't have to worry about driving other animals into extinction.
If we're going to be in anguish about losing a species, then now we have an opportunity to bring
them back. I mean, pick your favorite species and call up Colossal. And instead of raising money to
get animals on the endangered species, let's figure out a way to get them off. And this is
one tool and create biodiversity, what it can do for everybody. Let them go. We don't need regulations,
was his point, to protect animals. Any animal that disappears, we'll just clone it back.
And I think a lot of the company, Colossal, is worth $10 billion. It'd be great if we can help
animals that are on the verge of extinction and help them survive, given that we are losing,
as Colossal says, we're losing a lot of animals every year. And we will be losing more. Partly
due to climate change. Let's work on protecting those animals that are still here and have a
place to live. We've talked about a lot of the risks here, a lot of the drawbacks. I want to
talk about some of the potential benefits. Do you see some good there if we do indeed get
some medical or scientific breakthroughs out of this company's work? I mean, there's been talk of
rebalancing habitats, fixing mutations in endangered pink pigeons, vaccinating elephants
against herpes, sharpening our tools for fighting diseases. There's apparently some potential there.
So, unfortunately, at the moment, President Trump,
has been cutting back hugely on research at NIH. And the National Institutes of Health
has funded immense amounts of research that have led to immense human benefit,
partly because it's been available for, in the public domain, research is published,
which this company hasn't published many of its key findings. So, you could argue that there is
a greater need to, A, focus public dollars on this, on research, which are now being drastically cut
and secondly, a question is whether or not the prime aim here is to help nature, help endangered
species, or to make money, right? And if, I think, as DT wrote in his piece, the company only plans
to create maybe three or five dire wolves, what's the point? Is it to develop science that they can
then sell, or is it to create these animals which create huge publicity? And this has been the front
cover of Time magazine. It's been on every major news network.
It's been on every major newspaper. They're trying, as I understand, to raise more money.
So, this gives them great profile. We're going to bring back these five animals.
But is it to help nature, or is it to raise more money? And this is sort of the poster child for
them. The woolly mammoth, too, which is their long-range goal, they say, well, it could lead to
meat and fur and tusks, and they may decrease global warming by tamping down permafrost.
Well, there's. There's decreasing amounts of tundra, icy tundra, for them to live. To have an industry of mammoth
fur and meat, you need a lot of these animals, and we don't have the space for them. Maybe Russian
Siberia somewhere does. Good luck with that. The Russians aren't exactly our best buddies at the
moment. And even if these animals do, wherever they walk, press down snow, the snow's going to
melt further because of climate change. So, you're not getting at the source of climate change.
So, I'm not sure how much the end result is going to be actually helping animals versus making money.
Dr. Klitzman, I thought of one silver lining in all of this. If what you're saying is true,
someone still cares about being on the cover of Time magazine.
You mean that we still have magazines?
Yes.
Yes. And I should say, I realize I'm coming across as very negative. I don't mean to come
across as negative. I think that science is very important.
I think given decreasing amounts of money for science, it would be great as we as a society
could spend it where it's going to lead to the most bang for the buck. We're at the cusp of,
for instance, new vaccines. All kinds of new vaccine research that NIH was about to start
is now ending. I think that near-term or low-hanging fruit is there that we can invest in
that will be able to help.
Dr. Robert Klitzman, Columbia University. Dr. Devin Schwartz made our show today. He
was edited by Jolie Myers, fact-checked by Laura Bullard, and mixed by Andrea Christen's
daughter and Patrick Boyd. My name's Sean Ramos-Viram. The show is Today Explained.
That was Today Explained, which is made by Vox. Today Explained comes out every day and
digs into all sorts of stuff in the news, from direwolves to doomsday preppers, allergies
to baby Botox. You can find them wherever you get your podcasts. I'm Wendy Zuckerman,
and regular Science Versus will be back next week.
I'll find you then.
Back to you then.
Podcast Summary
Key Points:
Colossal Biosciences claims to have created "dire wolves" by editing gray wolf DNA with 15 gene changes based on ancient DNA from 13,000- to 72,000-year-old specimens.
These animals are not true dire wolves; they are genetically modified gray wolves with altered traits, and scientists note significant risks due to unknown gene interactions and unintended side effects.
The company, founded by Ben Lamb and led by scientists like George Church and Beth Shapiro, raises over $400 million and is valued at $10 billion, primarily to advance biotech rather than restore ecosystems.
De-extinction is scientifically complex, ethically controversial, and currently unregulated, raising concerns about animal welfare, unintended health consequences, and the moral implications of reviving species extinct for thousands of years.
Critics argue that the project prioritizes profit, media attention, and technological demonstration over ecological benefit, and that it may distract from protecting currently endangered species.
The dire wolves are kept in confined enclosures, not released into the wild, and are not intended for breeding or ecological restoration.
Potential benefits include medical advances in gene editing, disease resistance, and biotechnology, though these have not been widely published or independently verified.
There is deep skepticism about whether de-extinction addresses climate change or biodiversity loss, as the proposed habitats are no longer viable and the process could exacerbate ecological harm.
Summary:
Colossal Biosciences claims to have created genetically engineered "dire wolves" by modifying gray wolf DNA using ancient genetic material from dire wolf remains. However, these animals are not true dire wolves—they are modified gray wolves with only 15 of 80 possible gene changes, and scientists caution that such edits may cause unforeseen health issues like deafness or blindness. The company, valued at over $10 billion, prioritizes biotech innovation and profit over ecological restoration or species conservation.
Critics highlight major ethical, scientific, and practical concerns: the process involves harming live animals for egg and embryo collection, lacks regulatory oversight, and may divert attention from protecting endangered species. The animals are currently housed in confined enclosures and not intended for release into the wild. While potential medical and scientific advancements are noted, the broader ecological and ethical implications—especially regarding animal welfare, climate change, and biodiversity—are deeply questionable.
The project has generated significant media attention, including a Time magazine cover, but many experts argue it reflects more technological spectacle than genuine ecological benefit. Ultimately, the effort raises urgent questions about the ethics of de-extinction, the motivations behind such projects, and whether they align with sustainable environmental stewardship.
FAQs
The animals are not true dire wolves. They are gray wolves whose DNA has been genetically modified to include traits from dire wolves, such as a lighter coat and larger teeth. Scientists made 20 genetic edits, but they are not fully identical to the extinct species.
Colossal extracted DNA from a 72,000-year-old dire wolf ear bone and a 13,000-year-old tooth. Using the gray wolf as a genetic template, they edited 15 genes to match known dire wolf traits, then implanted the modified DNA into gray wolf embryos.
They are not true de-extinct species. The animals are genetically engineered hybrids, not resurrected from extinction. The dire wolf went extinct around 14,000 years ago, and no viable DNA from that time has been fully recovered or used to recreate the species.
Major concerns include unintended health effects from gene editing, animal welfare issues due to confinement, and the fact that such efforts may divert funding and attention from protecting currently endangered species.
No, there are currently no specific regulations governing de-extinction. Guidelines are outdated and based on early experiments, such as a goat that lived only 10 minutes after being brought back.
Colossal aims to de-extinct the woolly mammoth, with the hope that such technology could help combat climate change by restoring ecosystems and improve biomedical knowledge, though this remains speculative.
Chat with AI
Loading...
Pro features
Go deeper with this episode
Unlock creator-grade tools that turn any transcript into show notes and subtitle files.